SEC Form 4 · accession 0001274225-18-000011
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis Langer
Director
Period of report
Jun 6, 2018
Accepted (ET)
Jun 8, 2018 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 6, 2018 | M | 3,609 | $21.29 | A | 43,352 | D | |
| Common Stock | Jun 6, 2018 | S | 3,609 | $39.3705 | D | 39,743 | D | |
| Common Stock | Jun 7, 2018 | M | 3,096 | $21.29 | A | 42,839 | D | |
| Common Stock | Jun 7, 2018 | S | 3,096 | $39.35 | D | 39,743 | D | |
| Common Stock | Jun 8, 2018 | M | 13,664 | $21.29 | A | 53,407 | D | |
| Common Stock | Jun 8, 2018 | S | 13,664 | $39.35 | D | 39,743 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $21.29 | Jun 6, 2018 | M | 3,609 | D | Dec 2, 2012 | Dec 2, 2021 | Common Stock | 3,609 | 16,760 | D |
| Non-Qualified Stock Option (right to buy) | $21.29 | Jun 7, 2018 | M | 3,096 | D | Dec 2, 2012 | Dec 2, 2021 | Common Stock | 3,096 | 13,664 | D |
| Non-Qualified Stock Option (right to buy) | $21.29 | Jun 8, 2018 | M | 13,664 | D | Dec 2, 2012 | Dec 2, 2021 | Common Stock | 13,664 | 0 | D |